Pleo Oryzae (Sanum Kehlbeck GmbH & Co. KG)
Welcome to the PulseAid listing for the Pleo Oryzae drug offered from Sanum Kehlbeck GmbH & Co. KG. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sanum Kehlbeck GmbH & Co. KG |
NON-PROPRIETARY NAME: | aspergillus flavus var. oryzae |
SUBSTANCE NAME: | ASPERGILLUS FLAVUS VAR. ORYZAE |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | SOLUTION/ DROPS |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2010-06-15 |
END MARKETING DATE: | 0000-00-00 |
Pleo Oryzae HUMAN OTC DRUG Details:
Item Description | Pleo Oryzae from Sanum Kehlbeck GmbH & Co. KG |
LABELER NAME: | Sanum Kehlbeck GmbH & Co. KG |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6([hp_X]/10mL) |
START MARKETING DATE: | 2010-06-15 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60681-0021_15f8962a-0abe-42cf-9766-15d8508ba34d |
PRODUCT NDC: | 60681-0021 |
APPLICATION NUMBER: | |
Other ASPERGILLUS FLAVUS VAR. ORYZAE Pharmaceutical Manufacturers / Labelers: